Still, results from pathway analysis are highly concordant to that recently published on fresh-frozen primary ACC, where a myc overexpressing subtype enriched in NOTCH activating mutations and associated with worse prognosis emerged from clustering by RNAseq and protein expression analysis9. The gene discussed is MYC; the disease is adrenal cortex carcinoma.